This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Health Stocks in Motion

Updated from 3:28 p.m. EDT

Shares of Alpharma (ALO) were among the best-performing health-related stocks Friday, rising 7.8% after the company posted first-quarter earnings that were ahead of expectations.

Excluding items, the generic drugmaker posted earnings of $19.3 million, or 37 cents a share, on sales of $378.1 million. Analysts polled by Thomson First Call were expecting earnings of 28 cents a share on sales of $378.2 million. A year ago the company earned $2.5 million, or 5 cents a share, on sales of $311.7 million. The strong year-over-year sales gains were attributed to higher generic pharmaceuticals business, which benefited from the launches of gabapentin capsules and tablets during the fourth quarter of 2004.

Despite the upbeat gabapentin sales news, the company said its U.S. generics business continues to face significant challenges. Looking ahead, Alpharma reiterated its 2005 earnings outlook, saying that it continues to believe 2005 results will not exceed 2004 levels. Results for 2005 will be affected by continued weakness in the company's U.S. generics business, it said, and by an absence of a benefit for U.S. tax losses in the consolidated tax provision. Shares traded up 79 cents to $10.89.

Harvard Bioscience (HBIO - Get Report) fell 9.3% after the company posted first-quarter results that fell below expectations. The company posted adjusted earnings of $806,000, or 3 cents a share, on sales of $22.4 million. Analysts were expecting earnings of 5 cents a share on sales of $23.4 million. A year ago the company earned $798,000, or 3 cents a share, on sales of $22.2 million. Despite the first-quarter shortfall, the company backed its 2005 earnings and sales guidance. In March the company said that it would post adjusted 2005 earnings of 22 cents to 26 cents a share on sales of $95 million to $100 million. Analysts are expecting earnings of 24 cents a share on sales of $99 million. Shares traded down 36 cents to $3.52.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
HBIO $5.64 -2.40%
JNJ $101.71 -0.62%
MRK $58.47 0.22%
WPI $85.73 0.00%
AAPL $128.76 -0.46%


DOW 18,085.72 -117.65 -0.65%
S&P 500 2,099.36 -8.42 -0.40%
NASDAQ 4,971.6870 -8.2140 -0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs